BMJ Publishing Group
|Jisc BMJ Transitional OA agreement 2023-2024
|Has the agreement been fully disclosed and published?
|01/01/2023 – 12/31/2024
|Consortia / Institution
Approximate range of annual corresponding author publications
|Comments on size/article output
|Uncapped publishing of funded articles (Standard Collection)
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
|Comments on cost development
|Fixed % increase over subscriptions and funded APC spend (Standard Collection)
Transformative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|BMJ agreement offers unlimited OA
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?
|Fully OA titles are included selectively
|Original research articles
What is the approximate share of access related costs of the overall agreement?
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS
|The practical implementation of the agreement will be assessed by Jisc throughout its term. This agreement uses RightsLink.
|OVERALL ASSESSMENT AND COMMENTS
|This agreement transitions a significant proportion of funded UK research publishing output towards open access, for an acceptable increase in previous subscription spend. The agreement includes flexible options for institutions regarding the publishing output included in the agreement. The efficacy of the agreement will be reviewed by Jisc throughout its term.
|Request contact to the licensee
|contact [at] esac-initiative [dot] org